US equities
|
MU
$1,064.00
▼-2.21%
NVDA
$235.29
▼-0.92%
SNDK
$1,634.59
▼-3.42%
PLTR
$198.18
▲+2.09%
AMD
$632.00
▼-2.15%
INTC
$108.97
▼-3.67%
SPCX
$163.06
▼-2.71%
META
$720.26
▼-0.15%
MU
$1,064.00
▼-2.21%
NVDA
$235.29
▼-0.92%
SNDK
$1,634.59
▼-3.42%
PLTR
$198.18
▲+2.09%
AMD
$632.00
▼-2.15%
INTC
$108.97
▼-3.67%
SPCX
$163.06
▼-2.71%
META
$720.26
▼-0.15%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about David DellaFave
Recent news which mentions David DellaFave
NIMA Partners and empowerDX, a division of Eurofins, Announce Strategic Partnership to Promote New Celiac Disease Genetic Risk Test
September 15, 2022
Tags
Nima Partners
Products
celiac disease
From
PRUnderground